GGrantIndex
Sort

53,477 grants matching addiction

Primary sensory neuron-targeted block of Cav3.2 for treatment of chronic neuropathic pain

$395,719
Hongwei Yu · Medical College Of Wisconsin · R61 · FY2020 · NS

Dopaminergic mechanisms for motivation and reinforcement learning

$395,688
Joshua D Berke · University Of California, San Francisco · R01 · FY2019 · DA

Genetic and Pharmacological Validation of CRMP2 Phosphorylation as a Novel therapeutic Target for Neuropathic Pain

$395,680
Rajesh Khanna · University Of Arizona · R01 · FY2020 · NS

Mechanisms of Probiotic Analgesia

$395,653
David J Klumpp · Northwestern University At Chicago · R01 · FY2015 · AT

CORE B: CAREER ENHANCEMENT

$395,634
Pamela May Ling · University Of California, San Francisco · U54 · FY2019 · HL

Microglial pruning of dopamine receptors and opioid abuse.

$395,625
Staci D Bilbo · Duke University · R01 · FY2024 · DA

Inhibitory cell types and circuits in the lateral hypothalamus

$395,616
Alexander Choi Jackson · University Of Connecticut Storrs · R01 · FY2019 · MH

Parallel MRI for High Field Neuroimaging

$395,615
Victor Andrew Stenger · University Of Hawaii At Manoa · R01 · FY2015 · DA

MU OPIOID RECEPTOR GENE IN HEROIN ADDICTS

$395,609
University Of Cincinnati · R01 · FY2003 · DA

Biomolecular Recognition and Binding Mechanisms

$395,608
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Drug Abuse Policy Surveillance System

$395,605
Ning Gong · Legal Science Partners, Llc · R44 · FY2018 · DA

Development of a novel therapeutic platform for smoking cessation and nicotine de-addiction

$395,566
Brendan Heiden · Flik Therapeutics, Inc. · R43 · FY2024 · DA

Rapalog Therapy in Heritable and Vigabatrin-Induced GABA Metabolic Disorders

$395,549
K Michael Gibson · Washington State University · R01 · FY2020 · EY

Rapalog Therapy in Heritable and Vigabatrin-Induced GABA Metabolic Disorders

$395,549
K Michael Gibson · Washington State University · R01 · FY2019 · EY

Regulation of Ras by Monoubiquitination

$395,520
Sharon L Campbell · Univ Of North Carolina Chapel Hill · R01 · FY2013 · GM

Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer

$395,515
Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Statistical methods in mHealth to signal interventional needs for mental health patients

$395,504
Ian James Barnett · University Of Pennsylvania · R01 · FY2022 · MH

Amygdala-cortical circuitry in reward encoding, expectation, and decision making

$395,495
Kate Wassum · University Of California Los Angeles · R01 · FY2019 · DA

C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations

$395,480
Sara Becker · Stanford University · P50 · FY2023 · DA

C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations

$395,479
Sara Becker · Stanford University · P50 · FY2025 · DA

C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations

$395,477
Sara Becker · Stanford University · P50 · FY2024 · DA

METRIC: Measurement, Education and Tracking in Integrated Care: Strategies to Increase Patient Engagement and Reduce Mental Health Disparities among Hispanics

$395,467
Holli Slater · University Of Texas Arlington · R15 · FY2015 · MD

Biobehavioral Heterogeneity of Crack Cocaine Dependence

$395,454
New York University School Of Medicine · R01 · FY2001 · DA

TAAR1 agonists for nicotine addiction

$395,454
Jun-Xu Li · State University Of New York At Buffalo · R01 · FY2023 · DA

FABPs: Novel Roles in Pain and Inflammation

$395,451
Martin Kaczocha · State University New York Stony Brook · R01 · FY2021 · DA